• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症幸存者纵向研究中阳性选择偏倚的风险:来自挪威全国睾丸癌幸存者研究的经验教训。

Risk of positive selection bias in longitudinal surveys among cancer survivors: Lessons learnt from the national Norwegian Testicular Cancer Survivor Study.

机构信息

Department of Oncology, National Resource Center for Late Effects after Cancer Treatment, Oslo University Hospital, Norway; Faculty of Medicine, University of Oslo, Norway.

Department of Oncology, National Resource Center for Late Effects after Cancer Treatment, Oslo University Hospital, Norway.

出版信息

Cancer Epidemiol. 2020 Aug;67:101744. doi: 10.1016/j.canep.2020.101744. Epub 2020 Jul 9.

DOI:10.1016/j.canep.2020.101744
PMID:32652337
Abstract

BACKGROUND

Selection bias due to non- or incomplete compliance is challenging in surveys. Using data from a longitudinal survey in testicular cancer survivors (TCSs), we identify factors predicting incomplete compliance.

METHOD

In a questionnaire-based national survey (1998-2016; three waves) 1,813 > 5 year TCSs were invited to report post-treatment adverse health outcomes (AHOs). We separated complete from partial participants (participation in all three waves versus participation only once or twice). At each wave we additionally identified responders and non-responders based on their questionnaire return at the respective wave. Multivariable logistic regression analysis identified associations between AHOs reported at the first wave and partial participation. Survival differences between Responders and Non-Responders were assessed by the Kaplan-Meier estimate and the logrank test. Level of significance: p < 0.05.

RESULTS

Of 1813 TCSs 1,346 TCSs (79 %) completed the first wave's questionnaire, and 783 (58 %) became complete and 653 (42 %) partial participants. Poor socio-economics, unhealthy life style, major co-morbidity and chemotherapy-related AHOs reported at the first survey wave were associated with a significant 1.5-1.9 times increased risk for partial participation. At the two last waves non-responders had significantly decreased overall survival compared with responders.

CONCLUSION

Our longitudinal study indicates positive selection bias during the 17 years of a longitudinal survey among TCSs, with fewer AHOs among Complete than among Partial Participants. If not sufficiently compensated for by data from external sources and/or statistical methods, attrition bias in longitudinal surveys may limit the external validity of findings related to cancer survivors' self-reported AHOs.

摘要

背景

由于不遵守或不完全遵守规定而导致的选择偏差在调查中是一个挑战。本研究利用睾丸癌幸存者(TCSs)纵向研究的数据,确定了预测不完全遵守规定的因素。

方法

在一项基于问卷调查的全国性研究(1998-2016 年;共 3 个波次)中,邀请了 1813 名 >5 年的 TCSs 报告治疗后不良健康结局(AHOs)。我们将完全参与者和部分参与者(参加所有 3 个波次或仅参加 1 次或 2 次)分开。在每个波次,我们还根据各自波次的问卷回复情况,确定了应答者和非应答者。多变量逻辑回归分析确定了在第 1 波次报告的 AHOs 与部分参与之间的关联。通过 Kaplan-Meier 估计和对数秩检验评估了应答者和非应答者之间的生存差异。显著性水平:p<0.05。

结果

在 1813 名 TCSs 中,有 1346 名(79%)完成了第 1 波次的问卷,其中 783 名(58%)成为完全参与者,653 名(42%)成为部分参与者。较差的社会经济学状况、不健康的生活方式、主要合并症和第 1 次调查波次报告的化疗相关 AHOs 与部分参与的显著 1.5-1.9 倍风险增加相关。在最后两个波次中,非应答者的总生存率明显低于应答者。

结论

我们的纵向研究表明,在 TCSs 进行的 17 年纵向研究中存在积极的选择偏差,完全参与者的 AHOs 比部分参与者少。如果不通过外部来源和/或统计方法的数据充分补偿,纵向研究中的流失偏差可能会限制与癌症幸存者自我报告的 AHOs 相关的研究结果的外部有效性。

相似文献

1
Risk of positive selection bias in longitudinal surveys among cancer survivors: Lessons learnt from the national Norwegian Testicular Cancer Survivor Study.癌症幸存者纵向研究中阳性选择偏倚的风险:来自挪威全国睾丸癌幸存者研究的经验教训。
Cancer Epidemiol. 2020 Aug;67:101744. doi: 10.1016/j.canep.2020.101744. Epub 2020 Jul 9.
2
Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective.长期睾丸癌幸存者的不良健康结局与全球生活质量:30年纵向研究视角
Ann Oncol. 2023 Dec;34(12):1165-1174. doi: 10.1016/j.annonc.2023.09.3101. Epub 2023 Sep 21.
3
Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.北美睾丸癌幸存者接受现代顺铂化疗后不良健康结局的多机构评估
J Clin Oncol. 2017 Apr 10;35(11):1211-1222. doi: 10.1200/JCO.2016.70.3108. Epub 2017 Feb 27.
4
Aspects of posttraumatic stress disorder in long-term testicular cancer survivors: cross-sectional and longitudinal findings.长期睾丸癌幸存者的创伤后应激障碍相关方面:横断面研究与纵向研究结果
J Cancer Surviv. 2016 Oct;10(5):842-9. doi: 10.1007/s11764-016-0529-4. Epub 2016 Feb 26.
5
Longitudinal kidney function outcome in aging testicular cancer survivors.衰老的睾丸癌幸存者的纵向肾功能结果。
Acta Oncol. 2020 Apr;59(4):467-474. doi: 10.1080/0284186X.2020.1724328. Epub 2020 Feb 11.
6
The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors.神经质的人格特质与睾丸癌幸存者的长期发病密切相关。
Acta Oncol. 2009;48(6):842-9. doi: 10.1080/02841860902795232.
7
Limited evidence of non-response bias despite modest response rate in a nationwide survey of long-term cancer survivors-results from the NOR-CAYACS study.尽管全国性长期癌症幸存者调查的回复率不高,但仍有有限的证据表明不存在无应答偏倚——NOR-CAYACS 研究结果。
J Cancer Surviv. 2019 Jun;13(3):353-363. doi: 10.1007/s11764-019-00757-x. Epub 2019 Apr 16.
8
Chronic cancer-related fatigue in long-term survivors of testicular cancer.睾丸癌长期幸存者的慢性癌症相关疲劳
J Psychosom Res. 2008 Apr;64(4):363-71. doi: 10.1016/j.jpsychores.2008.01.002.
9
Adverse Health Outcomes and Associations with Self-Reported General Health in Childhood Lymphoma Survivors.儿童淋巴瘤幸存者的不良健康结局及其与自我报告的总体健康状况的关联
J Adolesc Young Adult Oncol. 2017 Sep;6(3):470-476. doi: 10.1089/jayao.2017.0018. Epub 2017 Aug 24.
10
Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors.睾丸癌治疗后的死亡率和第二癌症发生率:心理社会健康和生活方式是可改变的预后因素。
J Clin Oncol. 2022 Aug 10;40(23):2588-2599. doi: 10.1200/JCO.21.02105. Epub 2022 Apr 5.

引用本文的文献

1
A study of subjective memory impairment in long-term testicular cancer survivors.一项关于长期睾丸癌幸存者主观记忆障碍的研究。
Br J Cancer. 2025 Jul 10. doi: 10.1038/s41416-025-03108-z.
2
Health-related quality of life in patients with aggressive non-Hodgkin lymphoma: results from the PETAL trial.侵袭性非霍奇金淋巴瘤患者的健康相关生活质量:PETAL试验结果
Ann Hematol. 2025 May 21. doi: 10.1007/s00277-025-06402-1.
3
Biochemical Hypogonadism in Aging Testicular Cancer Survivors: A Clinical Challenge.老年睾丸癌幸存者的生化性腺功能减退:一项临床挑战。
Eur Urol Open Sci. 2025 Jan 17;72:10-16. doi: 10.1016/j.euros.2024.12.010. eCollection 2025 Feb.
4
Registry versus claims-based index dates for studies of cancer diagnosis in administrative data.行政数据中癌症诊断研究的登记日期与基于索赔的索引日期对比
Cancer Causes Control. 2025 May;36(5):539-550. doi: 10.1007/s10552-024-01953-6. Epub 2025 Jan 9.
5
Long-term cardiac effects of modern treatment for Hodgkin's lymphoma.霍奇金淋巴瘤现代治疗的长期心脏影响。
Cardiooncology. 2024 Apr 4;10(1):19. doi: 10.1186/s40959-024-00222-4.
6
Head and neck cancer patients with geriatric deficits are more often non-responders and lost from follow-up in quality of life studies.头颈部癌症合并老年综合征的患者在生活质量研究中更常出现无应答和失访。
Eur Arch Otorhinolaryngol. 2024 May;281(5):2619-2626. doi: 10.1007/s00405-024-08528-w. Epub 2024 Mar 1.
7
Adolescent and Young Adult Germ Cell Tumors: Epidemiology, Genomics, Treatment, and Survivorship.青少年和年轻成人生殖细胞肿瘤:流行病学、基因组学、治疗和生存。
J Clin Oncol. 2024 Feb 20;42(6):696-706. doi: 10.1200/JCO.23.01099. Epub 2023 Oct 11.
8
New directions in cancer and aging: State of the science and recommendations to improve the quality of evidence on the intersection of aging with cancer control.癌症与衰老研究的新方向:科学现状与改善老龄化与癌症控制交叉领域证据质量的建议。
Cancer. 2022 May 1;128(9):1730-1737. doi: 10.1002/cncr.34143. Epub 2022 Feb 23.
9
Study retention and attrition in a longitudinal cohort study including patient-reported outcomes, fieldwork and biobank samples: results of the Netherlands quality of life and Biomedical cohort study (NET-QUBIC) among 739 head and neck cancer patients and 262 informal caregivers.在一项包括患者报告结局、实地工作和生物库样本的纵向队列研究中研究保留率和损耗率:739 例头颈部癌症患者和 262 例非正规照护者的荷兰生活质量和生物医学队列研究(NET-QUBIC)的结果。
BMC Med Res Methodol. 2022 Jan 22;22(1):27. doi: 10.1186/s12874-022-01514-y.
10
The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up.基于顺铂的化疗对睾丸癌幸存者心脏的影响:30 年随访。
Eur Heart J Cardiovasc Imaging. 2021 Mar 22;22(4):443-450. doi: 10.1093/ehjci/jeaa289.